http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 13 Aug 2026 16:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html <p class="bwalignc"> Strategic Partnership Accelerates Integration of Artificial Intelligence Across Operations </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the second quarter ended June 30, 2026, totaled $6.1 million, a 61% decrease from the quarter ended June 30, 2025. In the first half of 2025, the U.S. Food and Drug Administration ended a nationwide program that allowed pharmacies, including HealthWarehouse.com, to offer compounded GLP-1 prescription medications during a shortfall in supply of proprietary brand-name versions. </p><p> The Company reported a net loss of $414,000 and Adjusted EBITDA of negative $84,000 for the second quarter this year, versus http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html Thu, 13 Aug 2026 16:05:00 -0400 A.06822034 HEWA O.00064849 O.20026344 http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html <p class="bwalignc"> Strategic Partnership Accelerates Integration of Artificial Intelligence Across Operations </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the second quarter ended June 30, 2026, totaled $6.1 million, a 61% decrease from the quarter ended June 30, 2025. In the first half of 2025, the U.S. Food and Drug Administration ended a nationwide program that allowed pharmacies, including HealthWarehouse.com, to offer compounded GLP-1 prescription medications during a shortfall in supply of proprietary brand-name versions. </p><p> The Company reported a net loss of $414,000 and Adjusted EBITDA of negative $84,000 for the second quarter this year, versus http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html Thu, 13 Aug 2026 16:05:00 -0400 A.06822034 HEWA O.00064849 O.20026344 http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html <p class="bwalignc"> Strategic Partnership Accelerates Integration of Artificial Intelligence Across Operations </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the second quarter ended June 30, 2026, totaled $6.1 million, a 61% decrease from the quarter ended June 30, 2025. In the first half of 2025, the U.S. Food and Drug Administration ended a nationwide program that allowed pharmacies, including HealthWarehouse.com, to offer compounded GLP-1 prescription medications during a shortfall in supply of proprietary brand-name versions. </p><p> The Company reported a net loss of $414,000 and Adjusted EBITDA of negative $84,000 for the second quarter this year, versus http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html Thu, 13 Aug 2026 16:05:00 -0400 A.06822034 HEWA O.00064849 O.20026344 http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html <p class="bwalignc"> Strategic Partnership Accelerates Integration of Artificial Intelligence Across Operations </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the second quarter ended June 30, 2026, totaled $6.1 million, a 61% decrease from the quarter ended June 30, 2025. In the first half of 2025, the U.S. Food and Drug Administration ended a nationwide program that allowed pharmacies, including HealthWarehouse.com, to offer compounded GLP-1 prescription medications during a shortfall in supply of proprietary brand-name versions. </p><p> The Company reported a net loss of $414,000 and Adjusted EBITDA of negative $84,000 for the second quarter this year, versus http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html Thu, 13 Aug 2026 16:05:00 -0400 A.06822034 HEWA O.00064849 O.20026344 http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html <p class="bwalignc"> Strategic Partnership Accelerates Integration of Artificial Intelligence Across Operations </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the second quarter ended June 30, 2026, totaled $6.1 million, a 61% decrease from the quarter ended June 30, 2025. In the first half of 2025, the U.S. Food and Drug Administration ended a nationwide program that allowed pharmacies, including HealthWarehouse.com, to offer compounded GLP-1 prescription medications during a shortfall in supply of proprietary brand-name versions. </p><p> The Company reported a net loss of $414,000 and Adjusted EBITDA of negative $84,000 for the second quarter this year, versus http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html Thu, 13 Aug 2026 16:05:00 -0400 A.06822034 HEWA O.00064849 O.20026344 http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html <p class="bwalignc"> Strategic Partnership Accelerates Integration of Artificial Intelligence Across Operations </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the second quarter ended June 30, 2026, totaled $6.1 million, a 61% decrease from the quarter ended June 30, 2025. In the first half of 2025, the U.S. Food and Drug Administration ended a nationwide program that allowed pharmacies, including HealthWarehouse.com, to offer compounded GLP-1 prescription medications during a shortfall in supply of proprietary brand-name versions. </p><p> The Company reported a net loss of $414,000 and Adjusted EBITDA of negative $84,000 for the second quarter this year, versus http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html Thu, 13 Aug 2026 16:05:00 -0400 A.06822034 HEWA O.00064849 O.20026344 http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html <p class="bwalignc"> Strategic Partnership Accelerates Integration of Artificial Intelligence Across Operations </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the second quarter ended June 30, 2026, totaled $6.1 million, a 61% decrease from the quarter ended June 30, 2025. In the first half of 2025, the U.S. Food and Drug Administration ended a nationwide program that allowed pharmacies, including HealthWarehouse.com, to offer compounded GLP-1 prescription medications during a shortfall in supply of proprietary brand-name versions. </p><p> The Company reported a net loss of $414,000 and Adjusted EBITDA of negative $84,000 for the second quarter this year, versus http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html Thu, 13 Aug 2026 16:05:00 -0400 A.06822034 HEWA O.00064849 O.20026344 http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html <p class="bwalignc"> Strategic Partnership Accelerates Integration of Artificial Intelligence Across Operations </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the second quarter ended June 30, 2026, totaled $6.1 million, a 61% decrease from the quarter ended June 30, 2025. In the first half of 2025, the U.S. Food and Drug Administration ended a nationwide program that allowed pharmacies, including HealthWarehouse.com, to offer compounded GLP-1 prescription medications during a shortfall in supply of proprietary brand-name versions. </p><p> The Company reported a net loss of $414,000 and Adjusted EBITDA of negative $84,000 for the second quarter this year, versus http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+Second+Quarter+2026/26920706.html Thu, 13 Aug 2026 16:05:00 -0400 A.06822034 HEWA O.00064849 O.20026344 http://www.streetinsider.com/Earnings/Healthwarehouse.com%2C+Inc.+%28HEWA%29+Misses+Q1+EPS+by+1c/26470372.html <p>Healthwarehouse.com, Inc. (OTC: HEWA) reported Q1 EPS of ($0.01). Revenue for the quarter came in at $6.44 million.</p><p>For earnings history and earnings-related data on Healthwarehouse.com, Inc. (HEWA) <a href="http://www.streetinsider.com/ec_earnings.php?q=HEWA">click here</a>.</p> http://www.streetinsider.com/Earnings/Healthwarehouse.com%2C+Inc.+%28HEWA%29+Misses+Q1+EPS+by+1c/26470372.html Mon, 11 May 2026 17:01:59 -0400 HEWA http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Press+Releases/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html <p class="bwalignc"> New Partnerships and Technology Investments Support Next Phase of Growth </p> <p> CINCINNATI--(BUSINESS WIRE)-- HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2026, totaled $6.3 million, a 58% decrease from the quarter ended March 31, 2025, as the U.S. Food and Drug Administration ended a nationwide shortage that allowed pharmacies to make and offer compounded GLP-1 prescription medications during a shortfall in supply of brand-name versions. The Company reported a net loss of $361,000 and Adjusted EBITDA of negative $28,000 for the quarter. </p><p> HealthWarehouse.com, a technology company with a focus on healthcare http://www.streetinsider.com/Business+Wire/HealthWarehouse.com+Reports+Results+for+First+Quarter+2026/26468865.html Mon, 11 May 2026 16:05:00 -0400 A.06822034 A.40071301 HEWA O.00064849 O.16619048 O.20026344 http://www.streetinsider.com/Corporate+News/HealthWarehouse.com+sells+assets+to+UK+AI+firm+for+%2410+million/26394200.html <p>HealthWarehouse.com Inc. (OTCQB: HEWA) announced it entered into a strategic partnership with healthwords.ai, a UK-based healthcare artificial intelligence company, on April 23, 2026.</p> <p>Under the agreement, healthwords.ai will acquire certain assets of HealthWarehouse.com's direct-to-consumer business, including its direct-to-consumer website and U.S. customer base, for approximately $10.0 million.</p> <p>The transaction terms include $3.5 million in cash, a $3.6 million promissory note, and a 12.5% equity interest in healthwords.ai's parent company. The deal's completion depends on healthwords.ai fulfilling these financial terms.</p> <p>HealthWarehouse.com will provide fulfillment and other services to healthwords.ai once the transaction closes. The companies also entered into a separate service agreement as part http://www.streetinsider.com/Corporate+News/HealthWarehouse.com+sells+assets+to+UK+AI+firm+for+%2410+million/26394200.html Wed, 29 Apr 2026 16:00:13 -0400 A.40071301 HEWA O.00064849 O.16619048 http://www.streetinsider.com/Corporate+News/HealthWarehouse.com+sells+assets+to+UK+AI+firm+for+%2410+million/26394200.html <p>HealthWarehouse.com Inc. (OTCQB: HEWA) announced it entered into a strategic partnership with healthwords.ai, a UK-based healthcare artificial intelligence company, on April 23, 2026.</p> <p>Under the agreement, healthwords.ai will acquire certain assets of HealthWarehouse.com's direct-to-consumer business, including its direct-to-consumer website and U.S. customer base, for approximately $10.0 million.</p> <p>The transaction terms include $3.5 million in cash, a $3.6 million promissory note, and a 12.5% equity interest in healthwords.ai's parent company. The deal's completion depends on healthwords.ai fulfilling these financial terms.</p> <p>HealthWarehouse.com will provide fulfillment and other services to healthwords.ai once the transaction closes. The companies also entered into a separate service agreement as part http://www.streetinsider.com/Corporate+News/HealthWarehouse.com+sells+assets+to+UK+AI+firm+for+%2410+million/26394200.html Wed, 29 Apr 2026 16:00:13 -0400 A.40071301 HEWA O.00064849 O.16619048 http://www.streetinsider.com/Corporate+News/HealthWarehouse.com+sells+assets+to+UK+AI+firm+for+%2410+million/26394200.html <p>HealthWarehouse.com Inc. (OTCQB: HEWA) announced it entered into a strategic partnership with healthwords.ai, a UK-based healthcare artificial intelligence company, on April 23, 2026.</p> <p>Under the agreement, healthwords.ai will acquire certain assets of HealthWarehouse.com's direct-to-consumer business, including its direct-to-consumer website and U.S. customer base, for approximately $10.0 million.</p> <p>The transaction terms include $3.5 million in cash, a $3.6 million promissory note, and a 12.5% equity interest in healthwords.ai's parent company. The deal's completion depends on healthwords.ai fulfilling these financial terms.</p> <p>HealthWarehouse.com will provide fulfillment and other services to healthwords.ai once the transaction closes. The companies also entered into a separate service agreement as part http://www.streetinsider.com/Corporate+News/HealthWarehouse.com+sells+assets+to+UK+AI+firm+for+%2410+million/26394200.html Wed, 29 Apr 2026 16:00:13 -0400 A.40071301 HEWA O.00064849 O.16619048 http://www.streetinsider.com/Corporate+News/HealthWarehouse.com+sells+assets+to+UK+AI+firm+for+%2410+million/26394200.html <p>HealthWarehouse.com Inc. (OTCQB: HEWA) announced it entered into a strategic partnership with healthwords.ai, a UK-based healthcare artificial intelligence company, on April 23, 2026.</p> <p>Under the agreement, healthwords.ai will acquire certain assets of HealthWarehouse.com's direct-to-consumer business, including its direct-to-consumer website and U.S. customer base, for approximately $10.0 million.</p> <p>The transaction terms include $3.5 million in cash, a $3.6 million promissory note, and a 12.5% equity interest in healthwords.ai's parent company. The deal's completion depends on healthwords.ai fulfilling these financial terms.</p> <p>HealthWarehouse.com will provide fulfillment and other services to healthwords.ai once the transaction closes. The companies also entered into a separate service agreement as part http://www.streetinsider.com/Corporate+News/HealthWarehouse.com+sells+assets+to+UK+AI+firm+for+%2410+million/26394200.html Wed, 29 Apr 2026 16:00:13 -0400 A.40071301 HEWA O.00064849 O.16619048